|
Composition
|
Name
|
Position
|
Institution
|
|
Talía Sainz Costa
|
Facultativo Especialista de Área en Pediatría
Profesora Asociada
|
Hospital Universitario La Paz
Universidad Autónoma Madrid
|
|
Jorge Atucha Margolles
|
Técnico de Laboratorio
|
FIBHULP
|
|
Fernando Baquero Artigao
|
Facultativo Especialista de Área de Pediatría
Profesor Colboarador
|
Hospital Universitario La Paz
Universidad Complutense de Madrid
|
|
Blanco Bravo Queipo de Llano
|
Facultativo Especialista de Área de Pediatría
|
Hospital Universitario La Paz
|
|
Jorge Bustamante Amador
|
Investigador Predoctoral
|
Hospital Universitario La Paz
|
|
Francisco José Climent Alcalá
|
Facultativo Especialista de Área de Pediatría. Unidad de Patología Compleja
Colaborador docente
|
Hospital Universitario La Paz
Univesidad Autónoma de Madrid
|
|
Lucía Escolano Taravillo
|
Investigador Predoctoral
|
Hospital Universitario La Paz
|
|
Luis Escosa García
|
Facultativo Especialista de Área en Pediatría
|
Hospital Universitario La Paz
|
|
Jaime Delgado Pérez
|
Investigador Predoctoral
|
Hospital Universitario La Paz
|
|
Miguel García Boyano
|
Investigador Predoctoral
|
Hospital Universitario La Paz
|
|
Marta García Fernández de Villalta
|
Facultativo Especialista de Área de Pediatría
Colaborador Clínico Docente
|
Hospital Universitario La Paz
Univesidad Autónoma de Madrid
|
|
María Milagros García López de Hortelano
|
Médico Adjunto de Pediatría Hospitalaria y Enfermedades Infecciosas y Tropicales
Colaborador Clínico Docente
|
Hospital Universitario La Paz
Universidad Autónoma de Madrid
|
|
Isabel Mellado Sola
|
Médico Interno Residente
|
Hospital Universitario La Paz
|
|
María Pérez Pascual
|
Médica Adjunta en Pediatría
|
Hospital Universitario La Paz
|
|
Roi Piñeiro Pérez
|
Jefe Asociado del Servicio de Pediatría
|
Hospital General de Villalba
|
|
Paula Rodríguez Molino
|
Contrato Rio Hortega
|
Hospital Universitario La Paz
|
|
Germán Vallejo Palma
|
Investigador Predoctoral
|
Fundación GESIDA
|
Strategic Objective
1. Vertically acquired HIV infection in children: Comorbidities, biomarkers, HIV reservoir, new therapeutic approaches.
2. Epidemiology of Paediatric Tuberculosis is Spain: molecular epidemiology of drug resistant strains, new diagnostic tools and new drugs for TB: Pharmacodynamics in children and TB-drugs Off-label use in paediatrics.
3. Congenital infections: burden of disease, prompt diagnosis and in-utero and postnatal management, host immune response.
4. Epidemiology of imported and emergent diseases in children: Identification and management of emergent outbreaks. Immuno-pathogenesis, preventive measures and management.
5. Immunization strategies in children: immune response in high risk patient’s vaccine effectiveness and barriers.
Research Lines
• Vertically acquired HIV infection in children
- Immuno-pathogenesis: Immune-activation, inflammation and biomarkers
- Epidemiology, immuno-virological factors
- Comorbidities, long term follow-up, cardiovascular risk, bone disorders, metabolic abnormalities, neurocognitive impairment, renal dysfunction.
- Antiretroviral treatment: new drugs, resistances, dosage, toxicity in children, simplification strategies.
- HIV eradication: barriers, HIV reservoir, new antiretroviral drugs and other strategies to achieve HIV replication control.
- Gut Microbiota and bacterial traslocation intestinal as modulating factors for inflammation and immune-activation in HIV-infected children.
- Transition to adult care: barriers, strategies to maintain adherence to care.
• Epidemiology of paediatric Tuberculosis (TB).
- Epidemiology of paediatric TB. Paediatric cases as as a sentinel for burden of diseases.
- Molecular epidemiology of paediatric TB: resistant strains.
- Immuno-pathogenesis: New diagnostic tools in special Populations: HIV-infected, ID patients, migrants and Internationally adopted children
- Management of critical situations. Neonatal TB, multidrug resistant and extra-pulmonary TB.
• Omics for the diagnostis of pediatric TB
- New fixed-dosed combinations. Off label drugs in children. Pharmacodinamic and pharmacokinetic
• Congenital infectious disease
- Congenital Citomegalovirus and Toxoplasma infections: diagnostic barriers, prognostic factors, new therapeutic approaches.
- CHAGAS disease and congenital TB: diagnostic barriers, prognostic factors, pharmacokinetics in newborns and new drugs.
• Epidemiology of imported and emergent diseases in children
- Paediatric International Outbreaks: Epidemiology and public health impact: Zika. Rabies. Dengue. Chikungunya. Haemorragic fevers, Mers-co.
- Imported diseases in Spain: epidemiology and special populations: adopted, migrant, refugees, travelers and ID children
- Covid-19 disease in children: epidemiology, diagnostic markers,treatment.
• Immunization strategies in children, including high risk patients
- Immunization and vaccine response in special populations: immunocompromised children, transplant recipients, chronic patients, HIV-infected, migrants.
- Vaccine immunogenicity: barriers in paediatric populations.
- New challengies in vaccinology
• Microbiome in pediatric infectious diseases
- Microbiome-related biomarkers in food allergy and intolerances
- Microbiome-related biomarkers in childhood TB and other respiratory infections
- Social Determinants of Health in Pediatrics
- The burden of chronic disease in childhood
- Health-care associated Infections.
- The burden of antimicrobial resistance
- Antimicrobial stewardship in pediatrics
|